Can a cervical liquid zap persistent HPV? new trial aims to find out
NCT ID NCT07493824
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a liquid called Paiteling, applied directly to the cervix, can clear persistent high-risk HPV infections. The trial will enroll 115 women aged 25 to 65 who have had the same high-risk HPV type for at least two years. Researchers will check if the virus becomes undetectable 12 months after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Paiteling Antibacterial Liquid (applied locally to the cervix)
What this could lead to
If it works, this could offer a new topical treatment to help clear persistent high-risk HPV infections, potentially reducing cervical cancer risk.
What could go wrong
This is a single-arm, phase 4 study with no placebo group, so results may be less reliable. The treatment is applied locally and may not work for everyone; long-term safety and effectiveness are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT HR-HPV INFECTION OF THE CERVIX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••